Funding
Turn ideas into impact
Show Me
Due: December 23, 2027
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products – Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 – Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-HL-26-018
Due: December 23, 2027
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 – Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-HL-26-019
Due: December 23, 2027
Catalyze: Product Definition Medical Device Prototype Optimization (R33 – Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-HL-26-020
Due: December 23, 2027
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products – Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-HL-26-017
Due: December 31, 2027
NPS Cooperative Ecosystems Studies Units (CESU) Master Cooperative Agreements
Type
Cooperative Agreement
Source
Federal
Opp Number
P23AS00132
Due: January 4, 2028
DEVCOM ANALYSIS CENTER BROAD AGENCY ANNOUNCEMENT FOR APPLIED RESEARCH
Type
Cooperative Agreement
Source
Federal
Opp Number
W911NF-23-S-0003
Due: January 6, 2028
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAS-25-205
Due: January 6, 2028
Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)
Type
Cooperative Agreement
Source
Federal
Opp Number
PAR-25-062
Due: January 6, 2028
NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
US $500,000
Type
Cooperative Agreement
Source
Federal
Opp Number
PAR-25-188
Do you have a grant, incentive, funding competition, or other funding source to share?